BridgeMD
Prevention study for Lymphedema Arm
Official title Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer
ClinicalTrials.gov ID: NCT07233863
What this study is testing
- What it's testing
- This study aims to evaluate the effectiveness of the Lymphovenous Bypass (LVB) procedure compared to physiotherapy alone as secondary prevention of lymphedema in breast cancer patients undergoing axillary lymph node dissection.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Breast cancer patients aged ≥ 18 years with an ECOG score \> 1
- Breast cancer patients with post-axillary lymph node dissection diagnosed with stage 0 and I lymphedema.
- Those who have never undergone lymphedema physiotherapy.
You likely can't join if
- Patients with dermal backflow before axillary lymph node dissection (ALND).
- Patients with breast cancer lymphedema who are unable to undergo a 24-month follow-up at Dharmais Cancer Hospital.
- Patients with iodine allergy, severe asthma, decreased kidney function, pregnancy, or breastfeeding.
The study team makes the final eligibility decision.
Where it's taking place
- Jakarta, Jakarta Special Capital Region, Indonesia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jakarta, Jakarta Special Capital Region, Indonesia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.